Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Exelixis Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, February 22, 2013 - 11:09am
tags:
earnings, Exelixis
Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment
Motley Fool
Friday, February 22, 2013 - 11:08am
tags:
orphan drugs, Pluristem, FDA, placental expanded cells
FDA OKs Roche drug for late-stage metastatic breast cancer
Reuters
Friday, February 22, 2013 - 11:01am
tags:
Roche, metastatic breast cancer, breast cancer, Kadcyla
Labeling Considerations in the European Union and its Impact on Global Labeling Compliance
CP Wire
Friday, February 22, 2013 - 10:54am
tags:
Europe, labeling, compliance
Bausch & Lomb Owner Said to Seek Banks for IPO as Sale Falters
Bloomberg
Friday, February 22, 2013 - 10:49am
tags:
Bausch & Lomb, IPO, M&A
UCB - ConfometRx Collaborate
Yahoo/Zacks
Friday, February 22, 2013 - 10:48am
tags:
UCB, ConfometRx, G protein coupled receptors
In U.S., flu vaccine worked in just over half of those who got it
Reuters
Friday, February 22, 2013 - 10:46am
tags:
vaccines, Flu, flu vaccines
CHMP rejects Vivus diet pill again
Pharma Times, UK
Friday, February 22, 2013 - 10:45am
tags:
Vivus, Europe, Qsiva, Qsymia
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Reuters
Friday, February 22, 2013 - 10:44am
tags:
Elan, Tysabri, share repurchase
Glaxo Sued By Maryland AG Over Avandia Risks
Pharmalot
Friday, February 22, 2013 - 10:43am
tags:
GSK, Avandia, diabetes, Maryland
More Money? Vasella May Be A Novartis Consultant
Pharmalot
Friday, February 22, 2013 - 10:42am
tags:
Daniel Vasella, Novartis
J&J Discloses Government Investigations of Hips, Mesh
Bloomberg
Friday, February 22, 2013 - 10:41am
tags:
hip implants, JNJ, surgical mesh, DePuy
Sanofi Gets EU Backing for New Attempt at 6-in-1 Child Vaccine
Bloomberg
Friday, February 22, 2013 - 10:41am
tags:
Sanofi, Europe, vaccines, Infarix Hexa, GSK
Isis Pharmaceuticals Launches Trial, Hits Milestone
Motley Fool
Friday, February 22, 2013 - 10:39am
tags:
Isis Pharmaceuticals, ISIS-TTR, antisense, GSK, transthyretin amyloidosis, TTR-mediated amyloidosis
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Friday, February 22, 2013 - 10:38am
tags:
Achillion, AbbVie, JNJ, Gilead, Bristol-Myers Squibb
Regulators Await Gilead's Hep C Candidate
Seeking Alpha
Thursday, February 21, 2013 - 6:39pm
tags:
Gilead, hepatitis C, sofosbuvir
Lyrica matches UCB drug in Pfizer's latest epilepsy trial
Fierce Pharma
Thursday, February 21, 2013 - 12:34pm
tags:
Lyrica, UCB, epilepsy, Pfizer, Keppra
J&J’s Floyd Says Hip Sales Halted for Business, Not Safety
Bloomberg
Thursday, February 21, 2013 - 12:29pm
tags:
JNJ, hip implants
Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines
Seeking Alpha
Thursday, February 21, 2013 - 12:16pm
tags:
cervical cancer, vaccines, Advaxis, Inovio, ADXS11-001, HPV, ADXS-HPV, VGX-3100
Repros Therapeutics gets FDA go-ahead on testosterone drug study
Reuters
Thursday, February 21, 2013 - 12:10pm
tags:
FDA, testosterone, Repros Therapeutics, Androxal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.